Paul Hartmann (PHH2) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
24 Aug, 2026Executive summary
Organic revenue grew by 3.3% year-over-year to €1,252.0 million in H1 2026, with all core segments contributing to growth.
Adjusted EBITDA increased by €25.9 million to €151.7 million, with margin rising from 10.4% to 12.1%.
Net income rose sharply to €57.6 million from €18.1 million in the prior year period.
Financial highlights
Revenue: €1,252.0 million, up 3.3% year-over-year.
Adjusted EBITDA: €151.7 million, up from €125.8 million; margin at 12.1%.
EBIT (operating income): €88.3 million, up from €44.4 million.
EPS: €15.35, up from €4.46 year-over-year.
Operating cash flow: €126.2 million, up from €15.7 million.
Outlook and guidance
Expects moderate organic revenue growth and adjusted EBITDA between €270–310 million for FY 2026.
Anticipates higher material, energy, and freight costs in H2 2026 due to the Iran war, with only partial compensation through pricing.
Projects negative impact on 2027 results from new statutory health insurance rules and planned care reform.
Latest events from Paul Hartmann
- Q1 2026 delivered higher sales and EBITDA, with positive outlook despite cost headwinds.PHH2
Q1 2026 - 2025 saw 2.2% organic sales growth, higher EBITDA, and a stable €8.00 dividend amid market challenges.PHH2
Q4 2025 - Organic sales up 2.0% to €1.83bn, EBITDA margin at 10.7%, guidance confirmed.PHH2
Q3 2025 - Revenue up 1.6%, but profit and guidance down due to higher costs and market headwinds.PHH2
Q2 2025 - Sales and earnings rose across all segments, prompting a raised EBITDA outlook for 2024.PHH2
Q3 2024 - Strong H1 2024 results and raised EBITDA outlook reflect successful transformation and growth.PHH2
Q2 2024 - Record earnings and margin expansion achieved through transformation and innovation.PHH2
Q4 2024 - Q1 2025 saw Hartmann grow revenue and margin, with US and product innovation as key drivers.PHH2
Q1 2025